Alpha-Lipoic Acid in Preventing Peripheral Neuropathy in Patients Receiving Chemotherapy for Cancer

NCT00112996 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

244

Enrollment

OTHER

Sponsor class

Conditions

Neurotoxicity
Unspecified Adult Solid Tumor, Protocol Specific
Unspecified Childhood Solid Tumor, Protocol Specific

Interventions

DRUG: alpha-lipoic acid
OTHER: placebo

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]